Compound ID | 1341
Class: Beta-lactam (penicillin)
Spectrum of activity: | Gram-negative |
Details of activity: | Beta-Lactamase resistant. primarily for the treatment of multiple drug-resistant, Gram-Negative bacteria. Not active against Gram-positive bacteria or bacteria with altered penicillin-binding proteins |
Institute where first reported: | Beecham Pharmaceuticals (GSK, US) |
Year first mentioned: | 1982 |
Highest developmental phase: | Phase 4 |
Chemical structure(s): | |
Canonical SMILES: | CC1(C)[C@H](C(=O)O)N2C(=O)[C@]([C@H]2S1)(NC(=O)C(C3=CSC=C3)C(=O)O)OC |
Isomeric SMILES: | CC1([C@@H](N2[C@H](S1)[C@@](C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C |
InChI: | InChI=1S/C16H18N2O7S2/c1-15(2)9(12(22)23)18-13(24)16(25-3,14(18)27-15)17-10(19)8(11(20)21)7-4-5-26-6-7/h4-6,8-9,14H,1-3H3,(H,17,19)(H,20,21)(H,22,23)/t8?,9-,14+,16-/m0/s1 |
InChI Key: | BVCKFLJARNKCSS-DWPRYXJFSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/171758 |
External links: | |
Guide to Pharmacology: | temocillin |
Main Source: | https://academic.oup.com/jac/article/73/7/1848/4964016?searchresult=1 |
Citation: | https://aac.asm.org/content/22/4/535.long |